CA Stock MarketDetailed Quotes
PRN Profound Medical Corp
- 11.440
- +0.570+5.24%
15min DelayMarket Closed Nov 29 16:00 ET
282.13MMarket Cap-6313P/E (TTM)
11.480High11.260Low4.70KVolume11.370Open10.870Pre Close53.50KTurnover15.75052wk High0.02%Turnover Ratio24.66MShares9.55052wk Low-1.812EPS TTM247.64MFloat Cap36.730Historical HighLossP/E (Static)21.65MShs Float4.210Historical Low-1.79EPS LYR2.02%Amplitude--Dividend TTM6.48P/B1Lot Size--Div YieldTTM
Profound Medical Corp Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -46.68%-6.36M | -24.05%-6.35M | 12.45%-5.1M | 13.58%-22.3M | -6.03%-7.02M | 24.62%-4.34M | 8.06%-5.12M | 25.91%-5.82M | -15.38%-25.8M | -30.97%-6.62M |
| Net income from continuing operations | -68.30%-9.36M | 5.93%-6.92M | 8.04%-6.2M | 0.35%-28.57M | 6.49%-8.91M | -11.35%-5.56M | -24.03%-7.36M | 17.94%-6.74M | 6.61%-28.67M | 6.24%-9.53M |
| Operating gains losses | ---- | ---- | ---- | -15.64%232K | --0 | --0 | 3,041.67%353K | -57.14%-121K | 193.86%275K | 481.82%420K |
| Depreciation and amortization | -6.62%268K | 3.61%287K | 7.77%305K | -28.55%1.15M | 16.80%299K | -22.85%287K | -44.27%277K | -40.92%283K | -14.64%1.6M | -48.39%256K |
| Asset impairment expenditure | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --2.52M | ---- |
| Remuneration paid in stock | -16.92%604K | -8.79%768K | -18.49%767K | -19.37%3.42M | 60.53%907K | -39.77%727K | -47.08%842K | 7.54%941K | -41.18%4.24M | -76.59%565K |
| Other non cashItems | -29.61%126K | 129.27%188K | -99.73%1K | 871.33%1.1M | 873.47%477K | 878.26%179K | 130.60%82K | 268.69%365K | -133.65%-143K | -85.02%49K |
| Change In working capital | 5,969.70%2M | -198.83%-674K | 105.09%28K | 106.64%374K | 123.09%209K | 101.46%33K | 147.16%682K | 46.08%-550K | -541.85%-5.63M | -145.66%-905K |
| -Change in receivables | 332.03%297K | -246.77%-841K | 242.33%854K | 32.87%-956K | -323.81%-801K | 68.93%-128K | 225.11%573K | -64.38%-600K | -171.34%-1.42M | -107.48%-189K |
| -Change in inventory | 154.74%349K | -91.37%12K | 45.45%-180K | 118.94%353K | 171.40%407K | 148.58%137K | 136.48%139K | 47.70%-330K | 25.17%-1.86M | -22.32%-570K |
| -Change in prepaid assets | 157.80%281K | 202.97%306K | 51.92%553K | -0.64%-158K | 9.74%-732K | 505.56%109K | -72.18%101K | 33.33%364K | -101.28%-157K | 22.91%-811K |
| -Change in payables and accrued expense | 587.14%682K | -84.21%51K | -2,162.96%-557K | 514.51%1.06M | 244.31%847K | -158.82%-140K | 205.56%323K | 106.24%27K | 30.89%-255K | -72.08%246K |
| -Change in other working capital | 616.36%394K | 55.51%-202K | -5,736.36%-642K | 104.04%78K | 16.47%488K | 103.02%55K | 31.63%-454K | -108.09%-11K | -3,067.69%-1.93M | 355.43%419K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -46.68%-6.36M | -24.05%-6.35M | 12.45%-5.1M | 13.58%-22.3M | -6.03%-7.02M | 24.62%-4.34M | 8.06%-5.12M | 25.91%-5.82M | -15.38%-25.8M | -30.97%-6.62M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -251.85%-665K | -675K | 850.70%20.38M | -79.18%1.46M | -107.01%-491K | -312.36%-189K | 0 | 2,958.67%2.14M | 18.21%7.03M | 8,063.64%7.01M |
| Net issuance payments of debt | -248.17%-665K | -182.85%-676K | -149.46%-696K | -117.41%-1.2M | -106.92%-495K | -141.77%-191K | -198.75%-239K | -244.44%-279K | 1,891.97%6.92M | 7,257.00%7.16M |
| Net common stock issuance | --0 | --0 | --22.94M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | --0 | -99.58%1K | --0 | 914.45%2.67M | --4K | -98.81%2K | 168.54%239K | 40,283.33%2.42M | -95.91%263K | --0 |
| Net other financing activities | --0 | --0 | ---1.86M | ---- | ---- | ---- | ---- | ---- | -50.51%-149K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -251.85%-665K | ---675K | 850.70%20.38M | -79.18%1.46M | -107.01%-491K | -312.36%-189K | --0 | 2,958.67%2.14M | 18.21%7.03M | 8,063.64%7.01M |
| Net cash flow | ||||||||||
| Beginning cash position | -13.23%34.08M | -4.20%41.18M | -43.65%26.21M | -30.73%46.52M | -27.23%33.63M | -26.22%39.28M | -28.51%42.98M | -30.73%46.52M | -19.97%67.15M | -36.02%46.21M |
| Current changes in cash | -55.25%-7.03M | -37.23%-7.03M | 515.47%15.29M | -11.00%-20.83M | -2,025.13%-7.51M | 20.10%-4.53M | 7.92%-5.12M | 53.63%-3.68M | -10.37%-18.77M | 107.40%390K |
| Effect of exchange rate changes | 106.41%72K | -105.39%-76K | -317.81%-318K | 128.35%529K | 218.52%96K | 17.49%-1.12M | 206.02%1.41M | -83.89%146K | -864.75%-1.87M | -140.10%-81K |
| End cash Position | -19.34%27.12M | -13.23%34.08M | -4.20%41.18M | -43.65%26.21M | -43.65%26.21M | -27.23%33.63M | -26.22%39.28M | -28.51%42.98M | -30.73%46.52M | -30.73%46.52M |
| Free cash from | -46.68%-6.36M | -24.05%-6.35M | 12.45%-5.1M | 13.58%-22.3M | -6.03%-7.02M | 24.62%-4.34M | 8.06%-5.12M | 25.91%-5.82M | -12.40%-25.8M | -27.76%-6.62M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data